The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Clinical research
"Gender paradox" in outcome after percutaneous coronary intervention with paclitaxel eluting stents
Patrizia Presbitero1, MD; Guido Belli1, MD; Dennis Zavalloni1, MD; Marco L. Rossi1, MD; Veronica Lisignoli1*, MD; Giancarlo Barberis2, MD; Gabriele L. Gasparini1, MD; Melania Scatturin1; Emanuela Morenghi1, PhD; Paolo Pagnotta1, MD
1. Department of Invasive Cardiology, Istituto Clinico Humanitas Mirasole Spa, Rozzano, Italy; 2. Department of Invasive Cardiology; Casa di Cura Cellini, Torino, Italy
Aims: To evaluate in-hospital and long-term outcome of women undergoing percutaneous coronary intervention (PCI) with paclitaxel-eluting stents (PES) as compared to men and historic control
Sign in to read and download the full article
Forgot your password? No account yet?
Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
female genderpercutaneous coronary interventionpaclitaxel-eluting stent
Read next article
Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve ReValving System aortic valve bioprosthesis